Crinetics Pharmaceuticals, Inc. Cash and Cash Equivalents
Crinetics Pharmaceuticals, Inc. (CRNX) had Cash and Cash Equivalents of $55.50 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-03
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $55.50M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $114.34M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $101.54M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $110.90M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $55.50M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $114.34M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $101.54M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $110.90M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $53.73M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $94.57M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $264.55M 10-K · filed 2026-02-26 |
| 2024-09-30 | $317.27M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $302.16M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $395.92M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $54.90M 10-K · filed 2026-02-26 |
| 2023-09-30 | $142.79M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $39.55M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $41.19M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $32.67M 10-K · filed 2025-02-27 |
| 2022-09-30 | $30.91M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $62.29M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $145.55M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $200.69M 10-K · filed 2024-02-28 |
| 2021-09-30 | $161.54M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $178.77M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $105.58M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $93.09M 10-K · filed 2023-02-28 |
| 2020-09-30 | $117.82M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $160.81M 10-Q · filed 2021-08-10 |
| 2020-03-31 | $50.92M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $40.33M 10-K · filed 2022-03-30 |
| 2019-09-30 | $66.58M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $59.72M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $62.83M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $44.97M 10-K · filed 2021-03-30 |
| 2018-09-30 | $169.65M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $68.41M 10-Q · filed 2018-08-30 |
| 2017-12-31 | $14.19M 10-K · filed 2019-03-13 |